Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Untreated Melanoma”

80 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 80 results

Large-scale testing (Phase 3)Study completedNCT01515189
What this trial is testing

Phase 3 Trial in Subjects With Metastatic Melanoma Comparing 3 mg/kg Ipilimumab Versus 10 mg/kg Ipilimumab

Who this might be right for
Melanoma
Bristol-Myers Squibb 831
Testing effectiveness (Phase 2)UnknownNCT02023710
What this trial is testing

Bevacizumab Combined With Carboplatin Plus Paclitaxel Chemotherapy to Treat Metastatic Mucosal Melanoma

Who this might be right for
Melanoma
Peking University Cancer Hospital & Institute 182
Testing effectiveness (Phase 2)Study completedNCT00445965
What this trial is testing

Iodine I 131 Monoclonal Antibody 3F8 in Treating Patients With Central Nervous System Cancer or Leptomeningeal Cancer

Who this might be right for
Brain and Central Nervous System TumorsIntraocular MelanomaLung Cancer+7 more
Memorial Sloan Kettering Cancer Center 78
Testing effectiveness (Phase 2)Study completedNCT00053781
What this trial is testing

Perifosine in Treating Patients With Metastatic or Recurrent Malignant Melanoma

Who this might be right for
Melanoma (Skin)
NCIC Clinical Trials Group 18
Testing effectiveness (Phase 2)Study completedNCT00232726
What this trial is testing

Clinical Study of Previously Untreated Patients With Malignant Melanoma

Who this might be right for
Malignant MelanomaNeoplasm Metastasis
Clavis Pharma 42
Post-approval studies (Phase 4)Not Yet RecruitingNCT07459543
What this trial is testing

Assess the Safety, and Tolerability of Nivolumab + Relatlimab Fixed-Dose Combination (FDC) In Untreated, Unresectable or Metastatic Melanoma Participants In India

Who this might be right for
Untreated MelanomaUnresectable MelanomaMetastatic Melanoma
Bristol-Myers Squibb 30
Early research (Phase 1)Study completedNCT01001299
What this trial is testing

A Pharmacokinetic Study of RO5185426 in Combination With a Drug Cocktail in Patients With Metastatic Melanoma

Who this might be right for
Malignant Melanoma
Hoffmann-La Roche 25
Early research (Phase 1)Study completedNCT00020579
What this trial is testing

MS-275 in Treating Patients With Advanced Solid Tumors or Lymphoma

Who this might be right for
Cancer
National Institutes of Health Clinical Center (CC) 75
Very early researchEnded earlyNCT00499733
What this trial is testing

Cyclophosphamide and Cryoablation in Treating Patients With Advanced or Metastatic Epithelial Cancer

Who this might be right for
Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 19
Testing effectiveness (Phase 2)Study completedNCT03070392
What this trial is testing

Safety and Efficacy of IMCgp100 Versus Investigator Choice in Advanced Uveal Melanoma

Who this might be right for
Uveal Melanoma
Immunocore Ltd 378
Testing effectiveness (Phase 2)UnknownNCT04017897
What this trial is testing

The Combination of Anti-PD-1 With Radiotherapy in Previously Untreated Metastatic Melanoma

Who this might be right for
Melanoma
Yonsei University 52
Large-scale testing (Phase 3)Study completedNCT02905266
What this trial is testing

A Safety and Efficacy Study of Multiple Administration Regimens for Nivolumab Plus Ipilimumab in Subjects With Melanoma

Who this might be right for
Melanoma
Bristol-Myers Squibb 106
Not applicableEnded earlyNCT00897312
What this trial is testing

Effect of Biological Therapy on Biomarkers in Patients With Untreated Hepatitis C, Metastatic Melanoma, or Crohn Disease

Who this might be right for
Melanoma
Vanderbilt-Ingram Cancer Center 7
Early research (Phase 1)Study completedNCT00412581
What this trial is testing

Lenalidomide and Dacarbazine (DTIC) in Patients With Metastatic Melanoma

Who this might be right for
Melanoma
M.D. Anderson Cancer Center 28
Not applicableStudy completedNCT01715077
What this trial is testing

Study of Ipilimumab in the Immune System

Who this might be right for
Previously Untreated and Histologically Confirmed Stage III (Unresectable) or Stage IV Melanoma
University Health Network, Toronto 4
Testing effectiveness (Phase 2)Study completedNCT02681549
What this trial is testing

Pembrolizumab Plus Bevacizumab for Treatment of Brain Metastases in Metastatic Melanoma or Non-small Cell Lung Cancer (NSCLC)

Who this might be right for
MelanomaNon-small Cell Lung CancerBrain Metastasis
Yale University 41
Testing effectiveness (Phase 2)UnknownNCT04200040
What this trial is testing

A Clinical Study to Evaluate the Safety and Efficacy of OrienX010 in Unresectable Malignant Melanoma Patients

Who this might be right for
Melanoma (Skin)
OrienGene Biotechnology Ltd. 165
Testing effectiveness (Phase 2)Study completedNCT00107718
What this trial is testing

Anti-Tumor Activity Of SB-485232 In Patients With Previously Untreated Metastatic Melanoma

Who this might be right for
Melanoma
GlaxoSmithKline 64
Testing effectiveness (Phase 2)Study completedNCT03815058
What this trial is testing

Evaluate the Efficacy and Safety of Autogene Cevumeran (RO7198457) in Combination With Pembrolizumab Versus Pembrolizumab Alone in Participants With Previously Untreated Advanced Melanoma.

Who this might be right for
Advanced Melanoma
Genentech, Inc. 131
Testing effectiveness (Phase 2)Study completedNCT01673854
What this trial is testing

Phase II Safety Study of Vemurafenib Followed by Ipilimumab in Subjects With V600 BRAF Mutated Advanced Melanoma

Who this might be right for
Melanoma
Bristol-Myers Squibb 70
Load More Results